SCHEMBL21111053

SCHEMBL21111053

Nc1ccc(S(=O)(=O)OC2CCCCC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.47
CA2 P00918 5/20 0.47
CYP2D6 P10635 1/20 0.43
TSHR P16473 3/20 0.42
HTR6 P50406 2/20 0.42
LMNA P02545 1/20 0.42
MPO P05164 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CA9 Q16790 3/20 0.41
CA12 O43570 2/20 0.41
CA14 Q9ULX7 2/20 0.41
CA5A P35218 2/20 0.41
CA7 P43166 2/20 0.41
CA5B Q9Y2D0 2/20 0.41
USP2 O75604 1/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41
CA13 Q8N1Q1 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7087946 0.84 CA1 (0.40) CA1CA2CYP2D6TSHRHTR6
SCHEMBL14780378 0.84 ENPP3 (0.48) CA1CA2CYP2D6USP2TDP1
SCHEMBL8370244 0.82 CYP2D6 (0.61) CA1CA2CYP2D6TSHRLMNA
SCHEMBL3443817 0.82 MAPK1 (0.51) CA1CA2CYP2D6CA9CA12
SCHEMBL8367865 0.82 CYP2D6 (0.61) CA1CA2CYP2D6TSHRLMNA
SCHEMBL23192021 0.82 CYP2D6 (0.61) CA1CA2CYP2D6TSHRLMNA
SCHEMBL9060935 0.82 CYP2D6 (0.61) CA1CA2CYP2D6TSHRLMNA
SCHEMBL22621292 0.82 CYP2D6 (0.61) CA1CA2CYP2D6TSHRLMNA
SCHEMBL24250706 0.82 CYP2D6 (0.61) CA1CA2CYP2D6TSHRLMNA
SCHEMBL6859221 0.82 CYP2D6 (0.47) CA1CA2CYP2D6LMNACA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3508478-B1 SALT DERIVATIVE OF TETRAHYDROISOQUINOLINE AND CRYSTALLINE THEREOF AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF CHINA STATE INST PHARM IND (CN) 2022-12-21 EP disclosed
EP-3508478-A1 SALT DERIVATIVE OF TETRAHYDROISOQUINOLINE AND CRYSTALLINE THEREOF AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF China State Institute of Pharmaceutical Industry (CN) 2019-07-10 EP disclosed
CN-101516874-A Pyrrole derivatives for the treatment of cytokine mediated diseases NOVARTIS AG (CH) 2009-08-26 CN disclosed